Tuning flux: Autophagy as a target of heart disease therapy

Current Opinion in Cardiology

Volumn 26, Issue 3, 2011, Pages 216-222

  Xie, Min ^a   Morales, Cyndi R ^a   Lavandero, Sergio ^a,c   Hill, Joseph A ^a,b  

^a Department of Internal Medicine ^*  (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

autophagy; cancer chemotherapy cardiotoxicity; cardiac hypertrophy; glycogen storage cardiomyopathy; heart failure; ischemic heart disease

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTOPHAGY; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CATABOLISM; ENVIRONMENTAL STRESS; GLYCOGEN STORAGE DISEASE; HEART DISEASE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AUTOPHAGY; CARDIOMEGALY; GLYCOGEN STORAGE DISEASE TYPE IIB; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 79955052480     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328345980a     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: Heart Disease and Stroke Statistics - 2011 update: a report from the American Heart Association. Circulation 2011; 123:459-463.
2. Rothermel BA, Hill JA. Autophagy in load-induced heart disease. Circ Res 2008; 103:1363-1369.
3. Yang Z, Klionsky DJ. Mammalian autophagy, core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22:124-131.
4. Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007; 27:19-40. (Pubitemid 351373346)
5. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-822.
6. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40:280-293.
7. Ravikumar B, Sarkar S, Davies JE, et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 2010; 90:1383-1435.
8. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132:27-42.
9. Gottlieb RA, Mentzer RM. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu Rev Physiol 2010; 72:45-59.
10. Shimomura H, Terasaki F, Hayashi T, et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 2001; 65:965-968.
11. Saijo M, Takemura G, Koda M, et al. Cardiomyopathy with prominent autophagic degeneration, accompanied by an elevated plasma brain natriuretic peptide level despite the lack of overt heart failure. InternMed 2004; 43:700-703. (Pubitemid 39264170)
12. Kostin S, Pool L, Elsasser A, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003; 92:715-724. (Pubitemid 36457635)
13. Kassiotis C, Ballal K, Wellnitz K, et al. Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation 2009; 120 (Suppl 11):S191-S197.
14. Tanaka Y, Guhde G, Suter A, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 2000; 406:902-906. (Pubitemid 30664267)
15. Yan L, Vatner DE, Kim SJ, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 2005; 102:13807-13812. (Pubitemid 41377660)
16. Lu L, Wu W, Yan J, et al. Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure. Int J Cardiol 2009; 134:82-90.
17. Nowis D, Maczewski M, Mackiewicz U, et al. Cardiotoxicity of the anticancer therapeutic agent bortezomib. Am J Pathol 2010; 176:2658-2668.
18. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005; 352:362-372.
19. Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406:906-910. (Pubitemid 30664268)
20. Raben N, Schreiner C, Baum R, et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder- murine Pompe disease. Autophagy 2010; 6:1078-1089.
21. Sugimoto S, Shiomi K, Yamamoto A, et al. LAMP-2 positive vacuolar myopathy with dilated cardiomyopathy. Intern Med 2007; 46:757-760. (Pubitemid 46902274)
22. Zbinden G, Bachmann E, Holderegger C. Model systems for cardiotoxic effects of anthracyclines. Antibiot Chemother 1978; 23:255-270.
23. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358:1370-1380.
24. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003; 107:984-991. (Pubitemid 36258721)
25. St John Sutton MG, Plappert T, Rahmouni H. Assessment of left ventricularsystolic function by echocardiography. Heart Fail Clin 2009; 5:177-190.
26. Zhu H, Tannous P, Johnstone JL, et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117:1782-1790.
27. Cao DL, Wang ZV, Battiprolu PK, et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci U S A 2011; 108:4123-4128.
28. Kong Y, Tannous P, Lu G, et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 2006; 113:2579-2588. (Pubitemid 43948006)
29. Nakai A, Yamaguchi O, Takeda T, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13:619-624. (Pubitemid 46828485)
30. Dennemarker J, Lohmuller T, Muller S, et al. Impaired turnover of autophagolysosomes in cathepsin L deficiency. Biol Chem 2010; 391:913-922.
31. Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100:914-922. (Pubitemid 46555697)
32. Zhang H, Bosch-Marce M, Shimoda LA, et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283:10892-10903.
33. Hariharan N, Zhai P, Sadoshima J. Oxidative stress stimulates autophagic flux during ischemia/reperfusion. Antioxid Redox Signal 2010. [Epub ahead of print]
34. Gurusamy N, Lekli I, Gorbunov NV, et al. Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein. J Cell Mol Med 2009; 13:373-387.
35. Valentim L, Laurence KM, Townsend PA, et al. Urocortin inhibits Beclin1- mediated autophagic cell death in cardiac myocytes exposed to ischaemia/ reperfusion injury. J Mol Cell Cardiol 2006; 40:846-852. (Pubitemid 43817043)
36. Yitzhaki S, Huang C, Liu W, et al. Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA. Basic Res Cardiol 2009; 104:157-167.
37. Huang C, Liu W, Perry CN, et al. Autophagy and protein kinase C are required for cardioprotection by sulfaphenazole. Am J Physiol Heart Circ Physiol 2010; 298:H570-H579.
38. Kobayashi S, Volden P, Timm D, et al. Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. J Biol Chem 2010; 285:793-804.
39. Miyata S, Takemura G, Kawase Y, et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 2006; 168:386-397. (Pubitemid 43271138)
40. Sala-Mercado JA, Wider J, Undyala VV, et al. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia- reperfusion injury. Circulation 2010; 122 (Suppl 11):S179-S184.
41. Sasaki H, Asanuma H, Fujita M, et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 2009; 119:2568-2577.